Abstraction Health

Lion's Mane Mushroom — Research Evidence

Source: PubMed / NCBI · human studies preferred · ranked by evidence qualityLast analyzed: May 25, 2026
🟡Moderate Evidence
10 studies·4 RCTs·6 reviews

The summary below was generated by an AI system (Claude) based on the studies listed. It is a synthesis tool, not a clinical opinion. Read individual studies for full context.

Lion's mane mushroom (Hericium erinaceus) has attracted growing scientific interest for its potential effects on cognitive function, mood, and neurological health. The current human evidence base consists of a small number of randomized controlled trials (RCTs), several narrative reviews, and a limited number of systematic reviews. Taken together, the research suggests there may be modest cognitive benefits — particularly for memory and attention — but the evidence is preliminary and should be interpreted with caution. No human trials support its use as a treatment for any diagnosed medical or psychiatric condition.

Key findings

  • A double-blind RCT in young adults found some improvements in cognitive performance (including short-term memory and attention) following 28 days of lion's mane supplementation at 1.8g, though the study was small and described as a pilot.
  • An earlier double-blind, placebo-controlled RCT found improvements on a cognitive function scale in older adults (ages 50–80) with mild cognitive impairment, suggesting a possible benefit in at-risk populations.
  • Systematic and narrative reviews identify biologically plausible mechanisms — including nerve growth factor (NGF) stimulation — that could support cognitive and mood effects, but most mechanistic evidence comes from preclinical (animal or cell-based) studies.
  • Optimal dosing, ideal formulation (whole mushroom vs. extract), and long-term safety have not been established; human trials have used varying doses and preparation methods, making cross-study comparisons difficult.
  • One review explored theoretical potential as an adjunct to antipsychotic treatment in schizophrenia, but this remains highly speculative with no direct clinical evidence.

Evidence gaps

  • ?All human RCTs to date are small, short-term, and largely from a limited number of research groups — larger, independent, and longer-duration trials are needed to confirm any benefits and establish optimal dosing.
  • ?It is unknown whether benefits observed in older adults with mild cognitive impairment translate to healthy young adults, or vice versa, as different populations have been studied in different trials without direct comparison.
  • ?The long-term safety profile, potential drug interactions, and effects of chronic use remain poorly characterized in human research.

Safety summary

Lion's mane appears to be generally well-tolerated in short-term human trials, with no serious adverse events prominently reported in the studies reviewed. However, long-term safety data in humans is lacking, and the optimal safe dose has not been established.

Studies (10)

Edible and Medicinal Fungi as Candidate Natural Antidepressants: Mechanisms and Nutritional Implications.

Systematic Review🟢
Key finding

Edible and Medicinal Fungi as Candidate Natural Antidepressants: Mechanisms and Nutritional Implications.

PMID: 40289452

Effect of nutritional supports on malnutrition, cognition, function and biomarkers of Alzheimer's disease: a systematic review.

Systematic Review🟢
Key finding

Effect of nutritional supports on malnutrition, cognition, function and biomarkers of Alzheimer's disease: a systematic review.

PMID: 35686376

The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study.

RCT🟡
Key finding

The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study.

PMID: 38004235

Improvement of cognitive functions by oral intake of Hericium erinaceus.

RCT🟡
Key finding

Improvement of cognitive functions by oral intake of Hericium erinaceus.

PMID: 31413233

Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial.

RCT🟡
Key finding

Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial.

PMID: 18844328

Acute Effects of Naturally Occurring Guayusa Tea and Nordic Lion's Mane Extracts on Cognitive Performance.

RCT🟡
Key finding

Acute Effects of Naturally Occurring Guayusa Tea and Nordic Lion's Mane Extracts on Cognitive Performance.

PMID: 38140277

A review of the effects of mushrooms on mood and neurocognitive health across the lifespan.

Review🟡
Key finding

A review of the effects of mushrooms on mood and neurocognitive health across the lifespan.

PMID: 38246232

Theoretical Potential of Hericium Erinaceus Supplementation as an Add-On to Antipsychotics in Chronic and Treatment-Resistant Schizophrenia.

Review🟡
Key finding

Theoretical Potential of Hericium Erinaceus Supplementation as an Add-On to Antipsychotics in Chronic and Treatment-Resistant Schizophrenia.

PMID: 39935672

The use of Hericium erinaceus and Trametes versicolor extracts in supportive treatment in oncology.

Review🟡
Key finding

The use of Hericium erinaceus and Trametes versicolor extracts in supportive treatment in oncology.

PMID: 32697746

A Mechanistic Review on Medicinal Mushrooms-Derived Bioactive Compounds: Potential Mycotherapy Candidates for Alleviating Neurological Disorders.

Review🟡
Key finding

A Mechanistic Review on Medicinal Mushrooms-Derived Bioactive Compounds: Potential Mycotherapy Candidates for Alleviating Neurological Disorders.

PMID: 32663897